SCHEMBL4852206

SCHEMBL4852206

COC(=O)c1cc(-c2nc(COc3ccc(C=O)cc3OC)c(C)o2)ccc1C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.52
MAPT P10636 3/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
HPGD P15428 2/20 0.48
CYP2C9 P11712 2/20 0.48
CYP1A2 P05177 1/20 0.48
HSP90AA1 P07900 1/20 0.48
CYP2C19 P33261 1/20 0.48
NPSR1 Q6W5P4 2/20 0.44
KDM4E B2RXH2 1/20 0.44
LMNA P02545 1/20 0.44
ALOX15 P16050 1/20 0.44
TSHR P16473 1/20 0.44
HSD17B10 Q99714 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
PPARG P37231 1/20 0.42
PPARA Q07869 1/20 0.42
TP53 P04637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4845400 0.88 ALDH1A1 (0.54) ALDH1A1MAPTSMN1; SMN2HPGDCYP2C9
SCHEMBL4853675 0.86 KDR (0.46) ALDH1A1MAPTSMN1; SMN2HPGDNPSR1
SCHEMBL4844166 0.85 PPARG (0.46) ALDH1A1MAPTSMN1; SMN2HPGDNPSR1
SCHEMBL4855222 0.85 ALDH1A1 (0.52) ALDH1A1MAPTSMN1; SMN2HPGDCYP2C9
SCHEMBL4848297 0.84 ALDH1A1 (0.58) ALDH1A1MAPTSMN1; SMN2HPGDCYP2C9
SCHEMBL4850825 0.83 ALDH1A1 (0.44) ALDH1A1MAPTSMN1; SMN2CYP2C9NPSR1
SCHEMBL6157314 0.81 ALDH1A1 (0.54) ALDH1A1MAPTSMN1; SMN2CYP2C9NPSR1
SCHEMBL4845465 0.81 ALDH1A1 (0.51) ALDH1A1MAPTSMN1; SMN2CYP2C9NPSR1
SCHEMBL4850654 0.79 ALDH1A1 (0.47) ALDH1A1MAPTSMN1; SMN2CYP2C9NPSR1
SCHEMBL4847764 0.78 PPARG (0.42) ALDH1A1MAPTSMN1; SMN2HPGDNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7368578-B2 Five-membered heterocyclic compounds TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-05-06 US disclosed
US-20060135578-A1 Five-membered heterocyclic compounds TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-06-22 US disclosed
EP-1541564-A1 FIVE-MEMBERED HETEROCYCLIC COMPOUNDS Takeda Pharmaceutical Company Limited (JP) 2005-06-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060135578-A1 Five-membered heterocyclic compounds GPR119, OR10J3, CYP11B1 ALDH1A1 821/4885MAPT 4700/4885SMN1; SMN2 4339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.